Get the app
US › Healthcare

Anteris Technologies Global Corp. Common Stock (AVR)

US · Healthcare · Medical Devices

$6.05-4.87%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$1.0M
Revenue YoY
+63.3%
Net profit
$-29.1M
EPS
$-0.30
EPS estimate
$-0.21
Net margin
-2,884.3%

EPS came in at -0.30 against a street estimate of -0.21 — a miss of 42.9%.

Key statistics

Market cap
$628.6M
Forward P/E
0.0
P/B
2.95
Book value
$2.58
EPS (TTM)
$-1.95
52-week high
$11.05
52-week low
$3.30
50-day MA
$8.34
200-day MA
$7.30
Beta
0.73

Analyst view

Analysts rate Anteris Technologies Global Corp. Common Stock a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $13.57.

Shareholding

Insiders
16.48%
Institutions
71.91%

Largest institutional holders

FundStake
L1 Capital Pty Ltd7.99%
FMR Inc7.05%
Nantahala Capital Management, LLC6.94%
BlackRock Inc5.92%
Sio Capital Management, LLC5.69%
Perceptive Advisors LLC3.51%
ADAR1 Capital Management LLC3.23%
Bvf Inc3.08%

Recent filings & reports

DocumentDate
Material agreement · Q3 2026
ANTERIS TECHNOLOGIES GLOBAL CORP. – FORM 8-K SUMMARY HEADLINE NUMBERS • Company: Anteris Technologies Global Corp. (Ticker: AVR, Nasdaq) • Filing Da
2026-09-23
Board / officer change · Q3 2026
ANTERIS TECHNOLOGIES GLOBAL CORP. – FORM 8-K SUMMARY HEADLINE NUMBERS • Wayne Paterson: 1,200,000 nonqualified stock options + 800,000 performance-b
2026-09-17
Board / officer change · Q3 2026
ANTERIS TECHNOLOGIES GLOBAL CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company appointed new Chief Financial Officer effective September 11, 2026 •
2026-09-08
Results announced · Q3 2026
ANTERIS TECHNOLOGIES GLOBAL CORP – Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Revenue (6 months to June 30, 2026): US$1,503,000 vs US$1,174,000 prio
2026-08-12
Quarterly report · Q2 2026
ANTERIS TECHNOLOGIES GLOBAL CORP. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash Position: $257.4 million in cash, cash equivalents and restricted c
2026-08-11
Reg FD disclosure · Q3 2026
ANTERIS TECHNOLOGIES GLOBAL CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Report Date: August 3, 2026 • Company: Anteris Technologies Global Corp. • T
2026-08-03
Reg FD disclosure · Q3 2026
ANTERIS TECHNOLOGIES GLOBAL CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company: Anteris Technologies Global Corp. (Nasdaq: AVR, ASX: AVR) • Ticker/
2026-07-31
Quarterly report · Q1 2026
ANTERIS TECHNOLOGIES GLOBAL CORP. – FORM 10-Q SUMMARY Quarter Ended March 31, 2026 --- HEADLINE NUMBERS • Cash position: $283.2 million as of March
2026-05-12

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Anteris Technologies Global Corp. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-10-19.